Administers company management and strives to align the Portraiers towards a mission.Graduated from Seoul National University College of Medicine and completed training at Seoul National University Hospital as an ophthalmologist.Holds a Master's degree in Clinical Medical Science and an MBA, and has experience in developing machine learning products at an IT startup, as well as sourcing license deals and developing AI analysis technologies.

Manages the development of Portrai's AI technologies related to drug development.Combines and analyzes existing imaging and genomic information of biological tissues with AI to create new insights and innovate the traditional drug development process.Currently a professor in the Department of Nuclear Medicine at Seoul National University, and has been consistently conducting related research since the early days of medical AI.

Leads basic scientific technologies for discovering new drug substances and exploring the relationship between new drugs and disease tissues.Explores meaningful drug-related assets through Portrai's technology and independently develops new drug candidates.Currently a professor at the Graduate School of Convergence Science and Technology at Seoul National University, and has produced various research outcomes in Theranostics through antibodies and nanomaterials.

Coordinates the process of applying Portrai's technology to actual medical practice.Applies and validates insights gained through Portrai's technology to various patients and reinterprets them with medical significance.Also collaborates with various departments within the hospital.Currently a professor of Thoracic Surgery at Seoul National University, and explores the integration of new technologies into medical practice from various angles.